Related Experiment Video
Updated: Jun 6, 2025
10:27
Controlled Microfluidic Environment for Dynamic Investigation of Red Blood Cell Aggregation
Published on: June 4, 2015
11.8K
Statin-treated RBC dynamics in a microfluidic porous-like network
Antonios Stathoulopoulos1, Carola S König2, Sudarshan Ramachandran3
1FluME, Department of Mechanical Engineering, University College London, London, UK.
Microvascular Research
|November 21, 2024
Summary
Statins improve red blood cell (RBC) flexibility, affecting how they move through microchannels. This study used microfluidics to show how statin treatment impacts RBC deformability and transport dynamics.
Area of Science:
- Biomedical Engineering
- Hematology
- Pharmacology
Background:
- Red blood cell (RBC) deformability is crucial for microcirculation.
- Therapeutic interventions can alter RBC properties, impacting blood flow.
- Statins are commonly prescribed drugs with potential effects on RBCs.
Purpose of the Study:
- To investigate the impact of statins on RBC deformability and microscale transport.
- To quantify changes in RBC behavior using a microfluidic platform.
- To explore the potential of microfluidics for personalizing therapeutic outcomes.
Main Methods:
- In vitro treatment of human RBCs with atorvastatin and rosuvastatin.
- Quantification of RBC deformability using a microfluidic ektacytometer (elongation index).
- Microfluidic pillar array perfusion experiments with Particle Tracking Velocimetry (PTV) and image processing.
Main Results:
- Statins significantly enhanced RBC deformability in a dose-dependent manner.
- Statin-treated RBCs exhibited straighter paths and lower velocities in microfluidic arrays.
- Enhanced deformation led to longer shape recovery times and altered flow dynamics.
Conclusions:
- Statins improve RBC deformability, influencing their microscale transport characteristics.
- Microfluidic analysis provides insights into RBC behavior under therapeutic influence.
- This in vitro approach may aid in optimizing therapeutic treatments for cardiovascular conditions.
